The Board of Directors of Hangzhou Biotest Biotech Co.,Ltd. has authorized a buyback plan on November 3, 2023.
Hangzhou Biotest Biotech Co.,Ltd.
Equities
688767
CNE1000050H0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.53 CNY | -1.52% | -2.96% | -5.75% |
1st Jan change | Capi. | |
---|---|---|
-5.75% | 418M | |
-4.92% | 12.11B | |
-5.82% | 8.07B | |
+5.43% | 5.67B | |
+26.16% | 5.48B | |
-9.58% | 4.12B | |
-59.63% | 2.75B | |
+8.44% | 2.62B | |
-3.70% | 2.33B | |
+21.00% | 2.11B |
- Stock Market
- Equities
- 688767 Stock
- News Hangzhou Biotest Biotech Co.,Ltd.
- Hangzhou Biotest Biotech Co.,Ltd. authorizes a Buyback Plan.